Alessandro Mazzetti

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne

Adelaide A. Hebert, Diane Thiboutot, Linda Stein Gold et al. · JAMA Dermatology · 2020 · 146 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris

Lawrence F. Eichenfield, Adelaide A. Hebert, Linda Stein Gold et al. · Journal of the American Academy of Dermatology · 2020 · 47 citations · Full text

Medicine, Dermatology, Pharmacology +8

Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study

Alessandro Mazzetti, Luigi Moro, Mara Gerloni et al. · PubMed · 2019 · 42 citations

Medicine, Dermatology, Pharmacology +14

Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro

Caridad Rosette, Frances J. Agan, Alessandro Mazzetti et al. · PubMed · 2019 · 37 citations

Life Sciences, Dermatology, Pharmacology +17

Virtualised e-Learning with real-time guarantees on the IRMOS platform

Tommaso Cucinotta, Fabio Checconi, Zlatko Zlatev et al. · 2010 · 30 citations · Full text

Computing, Cloud Computing, Computer Systems +17